Analyst Ratings for NLS Pharmaceutics (NLSP)

NLSP Rating Summary

  |   Expand Research on NLSP
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/29/2024 Laidlaw Yale Jen Downgrade Hold
(Buy)		 N/A
(N/A)		 0.19
(0.76)		 300% Details
9/14/2023 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 0.82
(0.76)		 -7.32% Details